Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

ICUI

ICU MEDICAL INC/DE

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 883984Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$2.23B
Net Income FY2025
$<0.01B
EPS (Basic, as reported)
$0.03
Net Margin FY2025
0.0%
ROE FY2025
0.0%
Total Equity
$2.12B
Shares Out
25M
Business description

ICU MEDICAL INC/DE — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2007–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 379 → 2,231 +21.8% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue3791,2931,4001,2661,2711,3162,2802,2592,3822,231
Cost of revenue(178)(867)(830)(794)(810)(825)(1,582)(1,519)(1,557)(1,409)
Gross profit201426570472461491698740825822
Research & development(13)(51)(53)(49)(43)(47)(93)(85)(89)(87)
Selling, general & administrative(89)(304)(328)(277)(284)(303)(608)(607)(639)(625)
Total operating expenses(118)(441)(548)(365)(363)(368)(741)(717)(782)(779)
Operating income83(15)2210798123(43)234343
Interest expense0(2)(1)(1)(2)(1)(71)(103)(107)(93)
Interest & investment income1—————————
Other income (expense), net1(2)1811(5)(6)(13)0
Pre-tax income85512211597——(78)(66)4
Income tax expense(22)(17)(6)(14)(11)(20)(40)(49)(52)(2)
Net income63692910187103(74)(30)(118)1
EPS — basic$3.90$3.50$1.41$4.90$4.16$4.86($3.11)($1.23)($4.83)$0.03
EPS — diluted$3.66$3.29$1.33$4.69$4.02$4.74($3.11)($1.23)($4.83)$0.03
Shares outstanding — basic (M)16202021212124242425
Shares outstanding — diluted (M)17212222222224242425

Showing the latest 10 of 19 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.